<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="sub-sub-section" /><meta name="keywords" content="Penicillins: broad spectrum; Ampicillin; Amoxicillin; Co-amoxiclav; Clavulanic acid: amoxicillin with; Clavulanic acid; Ampicillin: flucloxacillin with [co-fluampicil]; Flucloxacillin: ampicillin with [co-fluampicil]; Co-fluampicil; Lyme disease; Doxycycline: Lyme disease" /><meta name="IX" content="Penicillins: broad spectrum; Ampicillin; Amoxicillin; Co-amoxiclav; Clavulanic acid: amoxicillin with; Clavulanic acid; Ampicillin: flucloxacillin with [co-fluampicil]; Flucloxacillin: ampicillin with [co-fluampicil]; Co-fluampicil; Lyme disease; Doxycycline: Lyme disease" /><title>5.1.1.3 Broad-spectrum penicillins: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="265/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="35091.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="3723.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="3723.htm#pB" title="Skip Navigation">Skip Navigation</a><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=3723.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 26 May 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF No. 63 (March 2012)</a> &gt; <a href="2071.htm">5 Infections</a> &gt; <a href="3705.htm">5.1 Antibacterial drugs</a> &gt; <a href="3706.htm">5.1.1 Penicillins</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="129713.htm" title="Previous: TEMOCILLIN">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="3724.htm" title="Next: AMOXICILLIN">Next page</a> ►</div></div></div></div><div id="p1"><div id="pB"><h1 id="_3723">5.1.1.3 Broad-spectrum penicillins</h1><?highlighter on?><div id="pC" class="jN"><div><div id="_3723.3"><p><b><span>Ampicillin</span></b> is active against certain Gram-positive and Gram-negative
organisms but is inactivated by penicillinases including those produced
by <span class="cAC">Staphylococcus aureus</span> and by common Gram-negative
bacilli such as <span class="cAC">Escherichia coli</span>. Almost all
staphylococci, approx. 60% of <span class="cAC">E. coli</span> strains
and approx. 20% of <span class="cAC">Haemophilus influenzae</span> strains
are now resistant. The likelihood of resistance should therefore be
considered before using <span>ampicillin</span> for the ‘blind’
treatment of infections; in particular, it should not be used for
hospital patients without checking sensitivity.</p></div><p><span>Ampicillin</span> is well excreted
in the bile and urine. It is principally indicated for the treatment
of exacerbations of chronic bronchitis and middle ear infections,
both of which may be due to <span class="cAC">Streptococcus pneumoniae</span> and <span class="cAC">H. influenzae</span>, and for urinary-tract infections
(<a title=" Urinary-tract infections" href="3960.htm#_3960">section 5.1.13</a>).</p><p><span>Ampicillin</span> can be given by mouth but less
than half the dose is absorbed, and absorption is further decreased
by the presence of food in the gut.</p><div id="_208784"><p>Maculopapular rashes commonly occur with <span>ampicillin</span> (and <span>amoxicillin</span>) but are not usually related
to true penicillin allergy. They almost always occur in patients with
glandular fever; broad-spectrum penicillins should not therefore be
used for ‘blind’ treatment of a sore throat. The risk of rash is also
increased in patients with acute or chronic lymphocytic leukaemia
or in cytomegalovirus infection.</p></div><p><b><span>Amoxicillin</span></b> is a derivative of <span>ampicillin</span> and has a similar antibacterial spectrum. It
is better absorbed than <span>ampicillin</span> when given by
mouth, producing higher plasma and tissue concentrations; unlike <span>ampicillin</span>, absorption is not affected by the presence
of food in the stomach. <span>Amoxicillin</span> may also be
used for the treatment of Lyme disease [not licensed], see below.</p><p><b><span>Co-amoxiclav</span></b> consists of <span>amoxicillin</span> with the beta-lactamase inhibitor clavulanic acid. Clavulanic acid itself has
no significant antibacterial activity but, by inactivating beta-lactamases,
it makes the combination active against beta-lactamase-producing bacteria
that are resistant to <span>amoxicillin</span>. These include
resistant strains of <span class="cAC">Staph. aureus</span>, <span class="cAC">E. coli</span>, and <span class="cAC">H. influenzae</span>, as well
as many <span class="cAC">Bacteroides</span> and <span class="cAC">Klebsiella</span> spp. <span>Co-amoxiclav</span> should be reserved for infections
likely, or known, to be caused by <span>amoxicillin</span>-resistant
beta-lactamase-producing strains.</p><p>A combination of <span>ampicillin</span> with <span>flucloxacillin</span> (as <span>co-fluampicil</span>) is available
to treat infections involving either streptococci or staphylococci
(e.g. cellulitis).</p><div id="_3723.4"><div class="cAZ"><h2>Lyme disease</h2> <p class="cAX">Lyme disease should generally be treated by those experienced in
its management. <a title="monograph: DOXYCYCLINE" href="3816.htm#_3816"><b>Doxycycline</b></a>, <b>amoxicillin</b> [unlicensed
indication] or <b>cefuroxime axetil</b> are the antibacterials
of choice for <i>early Lyme disease</i> or <i>Lyme
arthritis</i>. If these antibacterials are contra-indicated,
a <b>macrolide</b> (e.g. clarithromycin) can be used for
early Lyme disease. Intravenous administration of <b>ceftriaxone</b>, <b>cefotaxime</b> (<a title="BNF:sub-sub-section: Cephalosporins" href="201577.htm#_201577">section 5.1.2.1</a>), or <b>benzylpenicillin</b> is recommended for Lyme disease associated
with cardiac or neurological complications. The duration of treatment
is usually 2–4 weeks; Lyme arthritis may require further treatment.</p></div></div><div id="_3723.2"><div class="cAZ"><h2>Oral infections</h2> <p class="cAX"><span>Amoxicillin</span> or <span>ampicillin</span> are as effective as <span>phenoxymethylpenicillin</span> (<a title="sub-sub-section: Benzylpenicillin and phenoxymethylpenicillin" href="3707.htm#_3707">section 5.1.1.1</a>) but
they are better absorbed; however, they may encourage emergence of
resistant organisms. Like <span>phenoxymethylpenicillin</span>, <span>amoxicillin</span> and <span>ampicillin</span> are ineffective against bacteria that produce beta-lactamases. <span>Amoxicillin</span> may be useful for short-course oral regimens.
Co-amoxiclav is active against beta-lactamase-producing bacteria that
are resistant to amoxicillin. Co-amoxiclav may be used for severe
dental infection with spreading cellulitis or dental infection not
responding to first-line antibacterial treatment.</p></div></div></div></div><?highlighter on?><div id="pS"><p>Sub-sections</p><ul class="jT"><li id="_3724"><a href="3724.htm" title="AMOXICILLIN">AMOXICILLIN</a></li><li id="_3728"><a href="3728.htm" title="AMPICILLIN">AMPICILLIN</a></li><li id="_3737"><a href="3737.htm" title="CO-AMOXICLAV">CO-AMOXICLAV</a></li><li id="_3739"><a href="3739.htm" title="CO-FLUAMPICIL">CO-FLUAMPICIL</a></li></ul></div><?highlighter off?><div id="pE">◄ <a accesskey="[" href="129713.htm">Previous: TEMOCILLIN</a> | <a class="top" href="3723.htm#">Top</a> | <a accesskey="]" href="3724.htm">Next: AMOXICILLIN</a> ►</div></div></div><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Privacy Policy">Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="35091.htm" rel="copyright">Copyright © BMJ Group and the Royal Pharmaceutical Society of Great Britain 2012. All rights reserved.</a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>